Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB
Assay data:3598 Active, 421 Activity ≤ 1 nM, 2233 Activity ≤ 1 µM, 3598 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Experimentally measured binding affinity data derived from PDB
Assay data:3073 Active, 3073 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice
Assay data:2633 Active, 47318 Tested
SummaryCompounds, Active
NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice
Assay data:1675 Active, 12988 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model P329 Reticulum Cell Sarcoma (intraperitoneal) in B6D2F1 (BDF1) mice
Assay data:27 Active, 80 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia resistant to Methyl-GAG; NSC 32946 (subcutaneous) in B6D2F1 (BDF1) mice
Assay data:36 Active, 137 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice
Assay data:50 Active, 134 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice
Assay data:25 Active, 381 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intracerebral) in CD2F1 (CDF1) mice
Assay data:36 Active, 167 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice
Assay data:1109 Active, 21196 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice
Assay data:1655 Active, 58883 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model Leiomyosarcoma (No. 2) (intraperitoneal) in CAF1 mice
Assay data:47 Active, 86 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model P288 Lymphocytic Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice
Assay data:53 Active, 161 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model P288 Lymphocytic Leukemia resistant to methotrexate; NSC 740 (intraperitoneal) in B6D2F1 (BDF1) mice
Assay data:31 Active, 101 Tested
NCI In Vivo Anticancer Drug Screen. Data for tumor model B16 Melanoma (intracerebral) in B6D2F1 (BDF1) mice
Assay data:19 Active, 134 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on